Time
1.1.2025–31.12.2028
Project coordinator
Åbo Akademi University
Other partners
Funded by
Budget
7 767 276 euros
Åbo Akademi University’s part of the budget
2 388 109 euros (31%)
The blood-brain barrier (BBB) is a major obstacle in treating diseases of the central nervous system (CNS) such as Parkinson’s, Alzheimer’s, schizophrenia and brain cancer, affecting 180 million Europeans with less than 5% of current candidate drugs effectively reaching the brain. NAP4DIVE strives to revolutionize the traditionally expensive and inefficient drug development for these diseases by establishing advanced non-animal alternatives for testing and predicting nanoparticle (NP)-based drug delivery across the human BBB. This approach aligns with EU and global initiatives to reduce animal testing and advance human-based biomedical research models.
Contact us
Cecilia Sahlgren (Principal Investigator)
Professor
Biochemistry and Cell Biology
Tel. +358 503009680
Jessica Rosenholm (Principal Investigator)
Professor
Pharmacy
Tel. +358 504605886
Hongbo Zhang (Principal Investigator)
Professor
Pharmacy
Tel. +358 503061491
Sebastien Lafond (Principal Investigator)
Professor
Information Technology
Tel. +358 405464024